AAAAAA

   
Results: 1-16 |
Results: 16
UNTITLED
Authors: RUSTIN G NEWLANDS E BOWER M
Citation: G. Rustin et al., UNTITLED, International journal of gynecological cancer, 8(2), 1998, pp. 175-175
CONTROL OF DELAYED NAUSEA AND VOMITING WITH GRANISETRON PLUS DEXAMETHASONE OR DEXAMETHASONE ALONE IN PATIENTS RECEIVING HIGHLY EMETOGENIC CHEMOTHERAPY - A DOUBLE-BLIND, PLACEBO-CONTROLLED, COMPARATIVE-STUDY
Authors: GOEDHALS L HERON JF KLEISBAUER JP PAGANI O SESSA C GIGER K CAVALLI F LUDWIG C AAPRO M BLEIBERG H DEWASH G DICATO M TAGNON A VANSTRAELEN D VINDEVOGHEL A ABRATT R FALKSON G BARLEY V CARMICHAEL J COLEMAN R DAVIDSON N GRIEVE R HARPER P ROBERTS J RUSTIN G NAMAN H SCHNEIDER M NOBLE A NETTER P CUPISSOL D BALMES P CALS L KHAYAT D CATIMEL G DUTIN JP BOUFETTE P ADENIS L MISSET J COLLERY P NOUVET G CHAVAILLON JM BLANCHON F POIRIER R ARNAUD A LECAER H CARLES P MUIR J BONNAUD F MARQUESTE L CLAVIER J GUERIN J TAYTARD A KEIZER H NORTIER J SLEE P WILS J RODENBURG C BURGHOUTS J DEWIT R GARCIAGIRON C JIMENEZLACAVE A CRUZHERNANDEZ J MASSUTISUREDA B HANS K FUCHS R KRIEGMAIR M SCHULLER J LAHOUSEN M PANNUTI F MONFARDINI S NILSSON S
Citation: L. Goedhals et al., CONTROL OF DELAYED NAUSEA AND VOMITING WITH GRANISETRON PLUS DEXAMETHASONE OR DEXAMETHASONE ALONE IN PATIENTS RECEIVING HIGHLY EMETOGENIC CHEMOTHERAPY - A DOUBLE-BLIND, PLACEBO-CONTROLLED, COMPARATIVE-STUDY, Annals of oncology, 9(6), 1998, pp. 661-666
IMPACT ON TUMOR PERFUSION MEASURED BY DYNAMIC MAGNETIC-RESONANCE-IMAGING (MRI), IN THE PHASE-1 TRIAL OF 5,6-DIMETHYLXANTHENONE-4-ACETIC ACID (DMXAA)
Authors: RUSTIN G GALBRAITH S TAYLOR N STRATFORD M BRADLEY C THOMPSON P JAMESON M BAGULEY B
Citation: G. Rustin et al., IMPACT ON TUMOR PERFUSION MEASURED BY DYNAMIC MAGNETIC-RESONANCE-IMAGING (MRI), IN THE PHASE-1 TRIAL OF 5,6-DIMETHYLXANTHENONE-4-ACETIC ACID (DMXAA), Annals of oncology, 9, 1998, pp. 483-483
ICON2 - RANDOMIZED TRIAL OF SINGLE-AGENT CARBOPLATIN AGAINST 3-DRUG COMBINATION OF CAP (CYCLOPHOSPHAMIDE, DOXORUBICIN, AND CISPLATIN) IN WOMEN WITH OVARIAN-CANCER
Authors: PARMAR MKB TORRI V BONAVENTURA A BONAZZI C COLOMBO N DELALOYE JF MARSONI S MANGIONI C SANDERCOCK J SESSA C WILLIAMS C TINAZZI A FLANN M GEISER K SCORPIGLIONE N STEWART JF CHAVES J PALMEIRO E CURTAIN A MCCORMACK T GENNATAS C MARRAS F OPPO TG BALESTRINO M MALZONI C MALZONI M BELLI M GEMINIANI ML CRESTANI G MONACO A VAVALA V PIATTO E BARATTINI G FORNARA PG CHETRI MC SANTEUFEMIA G ARTIOLI F CARONE D FANIZZA G TRENTADUE R PRIOLO D SCOLLO P NIGRO SC PETRINA M MASTRANTONIO P SPANNA GD ZAGNI R BELLONI C COLLEONI R REDAELLI L CAVAGNINI A DICOSTANZO G PERRONI D ARIENTI S ORFANOTTI G CANTONI FM SECLI R BIANCHI A MARTINELLO R MOLLICA G MAIZZI D PICCHIARELLI ME FIORINI G BORSANI M COLOMBO E GARSIA S MELGRATI L PAGGI G BRUNENGHI GM CASINI M ISA L ALGERI R PROZIO G BELFIORE G ANGELINI F DAPRILE M MORESCHI M MAURI ML NATALE N SENZANI FM PAVANATO G POGGI G GARUTI G LUERTI M CRUCIANI G PAGANO F BACCOLO M PODDI ER BOCCIOLONE L SABELLI MA MAGGI R RESTELLI C DANTONA A LOCATELLI MC PESSI A RAINA A CHIARI S GABRIELE A PITTELLI MR IACOBELLI P DOGLIOTTI L GORZEGNO G MUSSO P VEGNA G COCO G ALLETTI DG PICCIOTTO F LUCCHESE V EPIS A DIPALUMBO VS DRUDI G RAVAIOLI A ZAMPELLA D MORANDI MG GORGA G ZUCCHELLI C CARIELLO S GALLETTO L SUSSIO M MASSACESI L MASSACESI M CARLI A TUCCI E TAJANI E CORRADO G BUMMA S DURANDO A MASSOBRIO M SBERVEGLIERI M BIASIO M GUERCIO E JURA R DANESE S WIERDIS T FARNELLI C TARANTINO G GRASSI R REPETTI F ROCCHI B GRAMPA M ERCOLI A GRISO C SIGNORI E ZANINI L PRESTI M KLIMEK M URBANSKI K BISWAS A VIEGAS O KOCHLI O DREHER E FEY M BECK G LUDIN J BONNEFOI H KRAUER F BAUER J DELMORE G FURRER C LORENZ U THURLIMANN B LORENZ U BRONZ L SANNA P WYSS D GOLDHIRSCH A GYR T LEIDI L PASTORELLI G PAGANI O REY P HAILER U BENZ J KAYE SB REED NS SYMONDS RP ATKINSON RJ AXFORD AT RUSTIN G SECKL MJ GREEN JA SCOTT IV GUTHRIE D HARPER PG CALMAN F DOBBS HJ WEIR P CASSONI A LEDERMAN JA SOUHAMI RL BOZZINO J ADAB F REDMAN CWE SCOBLE JE PATERSON M DANIEL F COWLEY N WILLIAMS CJ SPOONER D HONG A MCILLMURRAY M HENDYIBBS P HALL V IVESON TJ WHITEHOUSE JMA GARRY R LAMONT A ROBINSON A TRASK CW CLUBB AW MURRELL D NEWMAN G WILKINS M GOLDTHORP WO ROBERTS JK RADSTONE DJ WHIPP MJ LEDERMANN JA PATER J BUYSE M OMURA G
Citation: Mkb. Parmar et al., ICON2 - RANDOMIZED TRIAL OF SINGLE-AGENT CARBOPLATIN AGAINST 3-DRUG COMBINATION OF CAP (CYCLOPHOSPHAMIDE, DOXORUBICIN, AND CISPLATIN) IN WOMEN WITH OVARIAN-CANCER, Lancet, 352(9140), 1998, pp. 1571-1576
O-6-METHYLGUANINE-DNA METHYLTRANSFERASE IN PRETREATMENT TUMOR-BIOPSIES AS A PREDICTOR OF RESPONSE TO TEMOZOLOMIDE IN MELANOMA
Authors: MIDDLETON MR LUNN JM MORRIS C RUSTIN G WEDGE SR BRAMPTON MH LIND MJ LEE SM NEWELL DR BLEEHEN NM NEWLANDS ES CALVERT AH MARGISON GP THATCHER N
Citation: Mr. Middleton et al., O-6-METHYLGUANINE-DNA METHYLTRANSFERASE IN PRETREATMENT TUMOR-BIOPSIES AS A PREDICTOR OF RESPONSE TO TEMOZOLOMIDE IN MELANOMA, British Journal of Cancer, 78(9), 1998, pp. 1199-1202
CHANGES IN HUMAN TUMOR PERFUSION AFTER DMXAA TREATMENT, MONITORED BY DYNAMIC GD-DTPA ENHANCED MRI
Authors: GALBRAITH SM TAYLOR NJ RUSTIN G BADDELEY H
Citation: Sm. Galbraith et al., CHANGES IN HUMAN TUMOR PERFUSION AFTER DMXAA TREATMENT, MONITORED BY DYNAMIC GD-DTPA ENHANCED MRI, British Journal of Cancer, 78, 1998, pp. 30-30
PROGNOSTIC FACTORS FOR PATIENTS WITH ADVANCED SEMINOMA TREATED WITH PLATINUM-BASED CHEMOTHERAPY
Authors: FOSSA SD OLIVER RTD STENNING SP HORWICH A WILKINSON P READ G MEAD GM ROBERTS JT RUSTIN G CULLEN MH KAYE SB HARLAND SJ COOK P
Citation: Sd. Fossa et al., PROGNOSTIC FACTORS FOR PATIENTS WITH ADVANCED SEMINOMA TREATED WITH PLATINUM-BASED CHEMOTHERAPY, European journal of cancer, 33(9), 1997, pp. 1380-1387
RADIOTHERAPY AFTER CHEMOTHERAPY FOR METASTATIC SEMINOMA - A DIMINISHING ROLE
Authors: DUCHESNE GM STENNING SP AASS N MEAD GM FOSSA SD OLIVER RTD HORWICH A READ G ROBERTS IT RUSTIN G CULLEN MH KAYE SB HARLAND SJ COOK PA
Citation: Gm. Duchesne et al., RADIOTHERAPY AFTER CHEMOTHERAPY FOR METASTATIC SEMINOMA - A DIMINISHING ROLE, European journal of cancer, 33(6), 1997, pp. 829-835
SINGLE-AGENT PACLITAXEL IN PATIENTS WITH PREVIOUSLY UNTREATED STAGE-IV EPITHELIAL OVARIAN-CANCER
Authors: GORE ME RUSTIN G SLEVIN M GALLAGHER C PENSON R OSBORNE R LEDERMANN J CAMERON T THOMPSON JM
Citation: Me. Gore et al., SINGLE-AGENT PACLITAXEL IN PATIENTS WITH PREVIOUSLY UNTREATED STAGE-IV EPITHELIAL OVARIAN-CANCER, British Journal of Cancer, 75(5), 1997, pp. 710-714
USE OF CA-125 IN FOLLOW-UP OF OVARIAN-CANCER
Authors: RUSTIN G TUXEN M
Citation: G. Rustin et M. Tuxen, USE OF CA-125 IN FOLLOW-UP OF OVARIAN-CANCER, Lancet, 348(9021), 1996, pp. 191-192
PACLITAXEL (TAXOL) IN RELAPSED AND REFRACTORY OVARIAN-CANCER - THE UKAND EIRE EXPERIENCE
Authors: GORE ME LEVY V RUSTIN G PERREN T CALVERT AH EARL H THOMPSON JM
Citation: Me. Gore et al., PACLITAXEL (TAXOL) IN RELAPSED AND REFRACTORY OVARIAN-CANCER - THE UKAND EIRE EXPERIENCE, British Journal of Cancer, 72(4), 1995, pp. 1016-1019
THE EFFICACY OF AUDIOTAPES IN PROMOTING PSYCHOLOGICAL WELL-BEING IN CANCER-PATIENTS - A RANDOMIZED, CONTROLLED TRIAL
Authors: MCHUGH P LEWIS S FORD S NEWLANDS E RUSTIN G COOMBES C SMITH D OREILLY S FALLOWFIELD L
Citation: P. Mchugh et al., THE EFFICACY OF AUDIOTAPES IN PROMOTING PSYCHOLOGICAL WELL-BEING IN CANCER-PATIENTS - A RANDOMIZED, CONTROLLED TRIAL, British Journal of Cancer, 71(2), 1995, pp. 388-392
SYNOPSIS OF WORKSHOP ON TREATMENT OF SOLID TUMORS
Authors: RUSTIN G
Citation: G. Rustin, SYNOPSIS OF WORKSHOP ON TREATMENT OF SOLID TUMORS, Leukemia, 8, 1994, pp. 85-86
TREATMENT OF GOOD-RISK, STAGE-II, NONSEMINOMATOUS TESTIS CANCER
Authors: BOSHOFF C RUSTIN G BEGENT R OLIVER T NEWLANDS E HOLDEN L ONG J
Citation: C. Boshoff et al., TREATMENT OF GOOD-RISK, STAGE-II, NONSEMINOMATOUS TESTIS CANCER, Lancet, 344(8929), 1994, pp. 1085-1086
THE PROGNOSTIC VALUE OF SERUM CA-125 IN PATIENTS WITH ADVANCED OVARIAN-CARCINOMA - AN ANALYSIS OF 573 PATIENTS BY THE MEDICAL-RESEARCH-COUNCIL WORKING PARTY ON GYNECOLOGICAL CANCER
Authors: FAYERS PM RUSTIN G WOOD R NELSTROP A LEONARD RCF WILKINSON P CRUICKSHANK D MCALLISTER EJ REDMAN CWE PARKER D SCOTT IV SLEVIN ML ROULSTON JE
Citation: Pm. Fayers et al., THE PROGNOSTIC VALUE OF SERUM CA-125 IN PATIENTS WITH ADVANCED OVARIAN-CARCINOMA - AN ANALYSIS OF 573 PATIENTS BY THE MEDICAL-RESEARCH-COUNCIL WORKING PARTY ON GYNECOLOGICAL CANCER, International journal of gynecological cancer, 3(5), 1993, pp. 285-292
ASSESSING THE BENEFITS OF ANTIEMETIC INNOVATION
Authors: REES GJ AAPRO MS CARMICHAEL J RUSTIN G HERRMANN R
Citation: Gj. Rees et al., ASSESSING THE BENEFITS OF ANTIEMETIC INNOVATION, Anti-cancer drugs, 4, 1993, pp. 5-8
Risultati: 1-16 |